The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.

Autor: McKenzie JA; Department of Melanoma Medical Oncology., Mbofung RM; Department of Melanoma Medical Oncology., Malu S; Department of Melanoma Medical Oncology., Zhang M; Department of Lymphoma/Myeloma., Ashkin E; Department of Melanoma Medical Oncology., Devi S; Department of Sarcoma Medical Oncology., Williams L; Department of Melanoma Medical Oncology., Tieu T; Institute for Applied Cancer Science., Peng W; Department of Melanoma Medical Oncology., Pradeep S; Department of Gynecologic Oncology and Reproductive Medicine., Xu C; Department of Melanoma Medical Oncology., Zorro Manrique S; Department of Melanoma Medical Oncology., Liu C; Department of Melanoma Medical Oncology., Huang L; Department of Melanoma Medical Oncology., Chen Y; Department of Melanoma Medical Oncology., Forget MA; Department of Melanoma Medical Oncology., Haymaker C; Department of Melanoma Medical Oncology., Bernatchez C; Department of Melanoma Medical Oncology., Satani N; Department of Cancer Imaging Systems., Muller F; Department of Cancer Imaging Systems., Roszik J; Department of Melanoma Medical Oncology., Kalra A; The University of Texas MD Anderson Cancer Center, Houston, TX; Merrimack Pharmaceuticals, Cambridge, MA., Heffernan T; Institute for Applied Cancer Science., Sood A; Department of Gynecologic Oncology and Reproductive Medicine.; Center for RNA Interference and Non-coding RNA., Hu J; Department of Biostatistics., Amaria R; Department of Melanoma Medical Oncology., Davis RE; Department of Lymphoma/Myeloma., Hwu P; Department of Melanoma Medical Oncology.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2018 Jul 01; Vol. 110 (7), pp. 777-786.